JPWO2021221111A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021221111A5
JPWO2021221111A5 JP2022518122A JP2022518122A JPWO2021221111A5 JP WO2021221111 A5 JPWO2021221111 A5 JP WO2021221111A5 JP 2022518122 A JP2022518122 A JP 2022518122A JP 2022518122 A JP2022518122 A JP 2022518122A JP WO2021221111 A5 JPWO2021221111 A5 JP WO2021221111A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
related diseases
rna virus
virus
preventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022518122A
Other languages
English (en)
Japanese (ja)
Other versions
JP7715353B2 (ja
JPWO2021221111A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/017002 external-priority patent/WO2021221111A1/ja
Publication of JPWO2021221111A1 publication Critical patent/JPWO2021221111A1/ja
Publication of JPWO2021221111A5 publication Critical patent/JPWO2021221111A5/ja
Application granted granted Critical
Publication of JP7715353B2 publication Critical patent/JP7715353B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022518122A 2020-04-30 2021-04-28 Rnaウイルス関連疾患の予防又は治療剤 Active JP7715353B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063017677P 2020-04-30 2020-04-30
US63/017,677 2020-04-30
US202063124098P 2020-12-11 2020-12-11
US63/124,098 2020-12-11
PCT/JP2021/017002 WO2021221111A1 (ja) 2020-04-30 2021-04-28 Rnaウイルス関連疾患の予防又は治療剤

Publications (3)

Publication Number Publication Date
JPWO2021221111A1 JPWO2021221111A1 (cg-RX-API-DMAC7.html) 2021-11-04
JPWO2021221111A5 true JPWO2021221111A5 (cg-RX-API-DMAC7.html) 2024-02-16
JP7715353B2 JP7715353B2 (ja) 2025-07-30

Family

ID=78374098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518122A Active JP7715353B2 (ja) 2020-04-30 2021-04-28 Rnaウイルス関連疾患の予防又は治療剤

Country Status (5)

Country Link
US (1) US20230147364A1 (cg-RX-API-DMAC7.html)
EP (1) EP4162952A4 (cg-RX-API-DMAC7.html)
JP (1) JP7715353B2 (cg-RX-API-DMAC7.html)
TW (1) TW202206058A (cg-RX-API-DMAC7.html)
WO (1) WO2021221111A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4129287A1 (en) * 2021-08-04 2023-02-08 Dompe' Farmaceutici S.P.A. Raloxifene for use in the treatment of sars-cov-2 variants infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105090A (en) * 1992-03-18 1998-08-16 Us Bioscience Acid N) phosphonoacetyl (Aspartic L in a broad spectrum antiviral agent
US20040175384A1 (en) * 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
JP5061352B2 (ja) 2006-01-04 2012-10-31 国立大学法人 東京医科歯科大学 肝臓疾患治療剤及び肝機能改善剤
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
US20120190637A1 (en) 2009-10-14 2012-07-26 Gemmus Pharma, Inc. Combination therapy treatment for viral infections
US10434116B2 (en) 2014-04-07 2019-10-08 University Of Maryland, Baltimore Methods of treating coronavirus infection
JP6528314B2 (ja) 2015-03-20 2019-06-12 国立大学法人山口大学 A(H1N1)pdm09インフルエンザウイルス感染による気管支喘息の予防又は改善剤

Similar Documents

Publication Publication Date Title
CN114786659B (zh) 用于治疗汉坦病毒感染的mek抑制剂
JP2007533686A5 (cg-RX-API-DMAC7.html)
JP2022551458A5 (cg-RX-API-DMAC7.html)
JP5523552B2 (ja) 薬物動態を改善する方法
JP2010513448A5 (cg-RX-API-DMAC7.html)
JP2015512406A5 (cg-RX-API-DMAC7.html)
RU2013103829A (ru) Многослойные пленки для доставки вкусоароматической добавки
WO2021147235A1 (zh) 法匹拉韦在治疗冠状病毒感染方面的应用
CN1268329C (zh) 起Raf/MEK/ERK信号级联的级联抑制剂作用的物质在制备治疗DNA和RNA病毒感染的药物中的应用
SE9702000D0 (sv) New pharmaceutical formulation
JP2004519469A5 (cg-RX-API-DMAC7.html)
JP2016506933A5 (cg-RX-API-DMAC7.html)
JP2012505884A5 (cg-RX-API-DMAC7.html)
JP2016534142A5 (cg-RX-API-DMAC7.html)
JP2010530376A5 (cg-RX-API-DMAC7.html)
HRP20240701T1 (hr) Pripravci za uporabu u liječenju hipertenzije
JP2013508282A (ja) ウイルス感染のための併用療法処置
JP2019536812A5 (cg-RX-API-DMAC7.html)
JP2020529995A5 (cg-RX-API-DMAC7.html)
JP2021515769A (ja) カプシド集合調節剤の投薬レジメン
WO2004064867A1 (en) Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
JP2023519277A (ja) 伝染性rnaウイルス感染症の予防又は治療するための医薬組成物
JP2022546424A5 (cg-RX-API-DMAC7.html)
JP2006516141A5 (cg-RX-API-DMAC7.html)
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel